Irinotecan Plus Mitomycin C as Second-Line Chemotherapy for Advanced Gastric Cancer Resistant to Fluoropyrimidine and Cisplatin: A Retrospective Study

Background. S-1 plus cisplatin has been established to be standard first-line chemotherapy for advanced gastric cancer in Japan. The optimal second-line treatment refractory to S-1 plus cisplatin remains unclear. Methods. We retrospectively studied the efficacy, toxicity, and survival of irinotecan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Kohei, Hosokawa, Ayumu, Ueda, Akira, Saito, Seiko, Mihara, Hiroshi, Ando, Takayuki, Kajiura, Shinya, Terada, Mitsuhiro, Tsukioka, Yuji, Horikawa, Naoki, Kobayashi, Takashi, Note, Masayuki, Sawasaki, Kunihiro, Fukuoka, Junya, Sugiyama, Toshiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296209/
https://www.ncbi.nlm.nih.gov/pubmed/22474446
http://dx.doi.org/10.1155/2012/640401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296209/
https://www.ncbi.nlm.nih.gov/pubmed/22474446
http://dx.doi.org/10.1155/2012/640401

Ejemplares similares